Your latest cannabis business info from Europe

Your latest cannabis business info from Europe


Bedrocan new production facility in Denmark

What is Bedrocan?

Bedrocan is a Dutch-based medical cannabis company. It specializes in the research, development, and production of standardized and consistent medical cannabis products. Since its founding in 1984, the business has developed into a market leader in the medical marijuana sector. It offers goods to patients, medical professionals, and researchers across the world. Products made by Bedrocan, now also produced in Denmark, are used to treat a variety of illnesses. The business is a favored supplier because of its commitment to quality, safety, and standardization.

The medical cannabis products made by Bedrocan meet the highest standards. They go through extensive testing to make sure their composition and potency are reliable. Bedrocan has partnered with businesses and organizations all over the world. All in addition to operating its own cultivation and processing facilities in the Netherlands. It was in order to increase its capacity for production and distribution. The company enhances knowledge about medical cannabis and improves patient outcomes via research and development.

Growth of Bedrocan in Denmark

Bedrocan, a Netherlands-based medical cannabis company, is expanding its production operations to Denmark. The new Bedrocan facility in Denmark will be situated in the city of Koge. It will have a production of medical marijuana, and will be in line with the tightest safety and quality requirements. Bedrocan’s aim to boost production and satisfy the rising demand for medical cannabis products in Europe includes the entry into Denmark. The new plant will adhere to the strictest Good Manufacturing Practice standards set by the European Union (GMP). Bedrocan’s aim to boost production and satisfy the rising demand for medical cannabis products in Europe includes the entry into Denmark.

Bedrocan’s current production operations, running since 2003 in the Netherlands, will include the new plant in Denmark. Products from Bedrocan treat a variety of illnesses, such as multiple sclerosis, epilepsy, and chronic pain. For patients who require exact dosages for their therapy, the company has a reputation for creating high-quality medical cannabis products that are standardized and consistent in their composition.

Future of Bedrocan

Bedrocan has reached an important milestone with its launch into Denmark. It now has a stronger opportunity to serve patients throughout Europe and other continents. With the new facility in Denmark, Bedrocan will be able to continue to grow and expand its operations. All to satisfy the demands of patients and healthcare providers. The company’s emphasis on quality and standardization has made it a leader in the medical cannabis business.

Several nations around the world sell medical cannabis products made by Bedrocan. These are: the Netherlands, Germany, Italy, the Czech Republic, Croatia, Israel, and Australia. To increase its production and distribution capacities, the company has also formed collaborations with other companies and groups in several areas. The legality of medicinal cannabis differs by nation and region. Bedrocan offers its products in nations where they can be a valid treatment option.


BZAM and 4C LABS: first shipment of medical cannabis to the UK

How the German Cannabis Association (DHV) can help in legalisation process?


Germany: protection zones with the “Bubatzkarte”

Promising future of medical cannabis in Spain: €335 Million by 2030